Tioga Cardiovascular key facts
as of Oct 2026- Manufacturer of medical equipment technology intended to provide valve replacement devices for mitral applications.
- Tioga Cardiovascular is valued at approximately $121.0M as of Oct 2026, set at its later-stage round, Sep 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $104.9M across 2 recorded rounds; the latest was Early Stage VC ($22.9M) in Aug 2025.
- Notable investors include Cormorant Asset Management, ShangBay Capital, TCP Health Ventures, AMED Ventures, PA MedTech VC Fund — 7 tracked in total.
- Tioga Cardiovascular has filed 2 Form Ds with the SEC since 2023, most recently Sep 2025 ($22.9M sold to 18 investors).
- Status: Privately Held (backing).
Valued at $121.0M at its later-stage round, Sep 2025. Nothing has traded since.
- ·Watch Tioga Cardiovascular: the Monday email on marks, rounds and moves
Tioga Cardiovascular funding rounds
2 roundsWho backs Tioga Cardiovascular
7Tioga Cardiovascular valuation
Tioga Cardiovascular was valued at $121 million at its later-stage round in Sep 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Tioga Cardiovascular raised?
Tioga Cardiovascular has raised $105 million in total; 2 of its rounds are on record. The largest on record was a $22.9 million early-stage round in Aug 2025.
Tioga Cardiovascular has filed 2 Form Ds with the SEC since 2023, most recently in Sep 2025 ($22.9 million sold to 18 investors).
Tioga Cardiovascular investors
7 investors are on record for Tioga Cardiovascular, including Cormorant Asset Management, ShangBay Capital, TCP Health Ventures and AMED Ventures. The early-stage round in Aug 2025 drew 18 investors.
About Tioga Cardiovascular
Manufacturer of medical equipment technology intended to provide valve replacement devices for mitral applications. The company's technology is procedurally simpler and uses a less invasive, transcatheter approach, and is focused on providing a new, elegant, valve replacement solution for mitral applications, enabling doctors to perform heart surgeries effectively and successfully.
- Sector
- Healthcare
- HQ
- Los Gatos, CA, United States
- Founded
- 2012
- Employees
- 21
- Website
- tiogacardiovascular.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.